China Shineway Pharmaceutical Group Limited (CSWYY)
OTC Markets OTCPK · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$16.79 (+0.00%) as of
Key statistics
- Market cap
- 634.16M
- P/E (TTM)
- 5.49
- EPS (TTM)
- 3.06
- Dividend yield
- 21.53%
- 52-week range
- 16.79 – 22.23
- Beta
- 0.68
- Revenue (TTM)
- 2.66B
- Profit margin
- 30.20%
- Volume
- 1.00
About China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Shijiazhuang, China
- Employees
- 2,656
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.